The ‘Transparency Effect’ in Pharmaceutical ESG Reports
As the pharmaceutical sector has become increasingly competitive, companies have adopted a plethora of strategies and practices not only to publicise their products but also to be perceived by stakeholders as transparent and, by way of implication, honest and ethical. Drawing on a corpus of English-...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Department of Foreign Languages and Literatures at the University of Verona
2025-06-01
|
| Series: | Iperstoria |
| Subjects: | |
| Online Access: | https://iperstoria.it/article/view/1510 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421444812898304 |
|---|---|
| author | Andrea Fenice Renzo Mocini |
| author_facet | Andrea Fenice Renzo Mocini |
| author_sort | Andrea Fenice |
| collection | DOAJ |
| description | As the pharmaceutical sector has become increasingly competitive, companies have adopted a plethora of strategies and practices not only to publicise their products but also to be perceived by stakeholders as transparent and, by way of implication, honest and ethical. Drawing on a corpus of English-language Environmental, Social and Governance (ESG) reports, this study investigates the complexity and dynamism of the discursive strategies used by leading pharmaceutical companies listed on the stock exchange to build and enhance an image of transparency and credibility. By distinguishing between the level of the utterance – what is being communicated – and the enunciational level (Greimas & Courtés 2007; Greimas 1983), which regards the writer and the context of enunciation, this paper conducts a semio-linguistic analysis in an attempt to explore different construals of transparency and opacity. The discourse of pharmaceutical companies is revealed as a sophisticated communicative construct, where various strategies are employed to create meaning effects that are used to foster an image of transparency and boost stakeholders’ trust. |
| format | Article |
| id | doaj-art-a89e1d7e8d4a44999c1c16fec0e89c3d |
| institution | Kabale University |
| issn | 2281-4582 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Department of Foreign Languages and Literatures at the University of Verona |
| record_format | Article |
| series | Iperstoria |
| spelling | doaj-art-a89e1d7e8d4a44999c1c16fec0e89c3d2025-08-20T03:31:27ZengDepartment of Foreign Languages and Literatures at the University of VeronaIperstoria2281-45822025-06-012510.13136/2281-4582/2025.i25.15101479The ‘Transparency Effect’ in Pharmaceutical ESG ReportsAndrea Fenice0Renzo Mocini1https://orcid.org/0000-0002-2011-3665Independent ResearcherSapienza University of RomeAs the pharmaceutical sector has become increasingly competitive, companies have adopted a plethora of strategies and practices not only to publicise their products but also to be perceived by stakeholders as transparent and, by way of implication, honest and ethical. Drawing on a corpus of English-language Environmental, Social and Governance (ESG) reports, this study investigates the complexity and dynamism of the discursive strategies used by leading pharmaceutical companies listed on the stock exchange to build and enhance an image of transparency and credibility. By distinguishing between the level of the utterance – what is being communicated – and the enunciational level (Greimas & Courtés 2007; Greimas 1983), which regards the writer and the context of enunciation, this paper conducts a semio-linguistic analysis in an attempt to explore different construals of transparency and opacity. The discourse of pharmaceutical companies is revealed as a sophisticated communicative construct, where various strategies are employed to create meaning effects that are used to foster an image of transparency and boost stakeholders’ trust.https://iperstoria.it/article/view/1510pharmaceutical esg reportstransparencyopacitysemiotic squareenunciation |
| spellingShingle | Andrea Fenice Renzo Mocini The ‘Transparency Effect’ in Pharmaceutical ESG Reports Iperstoria pharmaceutical esg reports transparency opacity semiotic square enunciation |
| title | The ‘Transparency Effect’ in Pharmaceutical ESG Reports |
| title_full | The ‘Transparency Effect’ in Pharmaceutical ESG Reports |
| title_fullStr | The ‘Transparency Effect’ in Pharmaceutical ESG Reports |
| title_full_unstemmed | The ‘Transparency Effect’ in Pharmaceutical ESG Reports |
| title_short | The ‘Transparency Effect’ in Pharmaceutical ESG Reports |
| title_sort | transparency effect in pharmaceutical esg reports |
| topic | pharmaceutical esg reports transparency opacity semiotic square enunciation |
| url | https://iperstoria.it/article/view/1510 |
| work_keys_str_mv | AT andreafenice thetransparencyeffectinpharmaceuticalesgreports AT renzomocini thetransparencyeffectinpharmaceuticalesgreports AT andreafenice transparencyeffectinpharmaceuticalesgreports AT renzomocini transparencyeffectinpharmaceuticalesgreports |